Insights

Two research pillars. One integrated view.

FinTech
Aug 31, 2026

The Dawn of Quantum Technology in Hong Kong Banking

The HKMA's Quantum Preparedness report finds Hong Kong banks at an early stage of readiness for both the opportunities and cybersecurity threats of quantum computing, with a PQC readiness score of just 2.3 out of 10 and a recommended four-stage path from awareness to practical preparedness.

Simon Chu
Biotech
Aug 27, 2026

The "Pill Penalty": Is It Priced In?

A factor-adjusted event study around five Medicare Drug Price Negotiation milestones finds that large-cap pharma with high exposure to small-molecule negotiation consistently underperformed less-exposed peers, suggesting the "pill penalty" is already being priced into equity valuations before negotiated prices take effect.

Kenzie Scott Wu and Diana Dai
Deflation
Aug 20, 2026

China Never Exited Deflation

China's recent producer price increases came from an oil-driven commodity shock, not recovered pricing power. Consumer-goods producer prices are still falling, overcapacity keeps factories selling below cost, and the deflation China exports to the world is still moving.

Eric Tao
Artificial Intelligence
Aug 11, 2026

Kimi vs Claude: Similar Intelligence, Different Paths

Kimi K3 and Claude Fable 5 show how quickly the frontier AI market is changing. Both target complex reasoning, coding, research and long-running agent tasks, but follow different strategies — Claude on reliable enterprise work, Kimi on long context, open weights, and lower prices.

Alice Liu
Artificial IntelligenceLabor Market
Aug 9, 2026

Artificial Intelligence Is Reshaping the Global Labor Market

Artificial intelligence is reshaping labor markets, productivity, investment, and inflation. By augmenting cognitive work rather than replacing entire occupations, AI is shifting how businesses hire, invest, and grow, with significant implications for the global economy.

Pranav Bhongir
Biotech
Jul 28, 2026

The Idiosyncratic Bet

AI native drug discovery is not a new asset class. It is a wager on shrinking the one part of biotech risk that has never been diversifiable: the probability that a molecule works. A factor decomposition framework shows that platform risk is idiosyncratic and diversifies away across names.

Diana Dai
FinTech
Jul 22, 2026

Real-Time Payments: From Competitive Edge to Operational Imperative

Real-time payments have shifted from a competitive advantage to basic financial infrastructure. With Singapore's PayNow surpassing 1.2 billion transactions, FedNow surging 459% year-on-year, and global cross-border networks connecting, instant settlement is now the expected norm.

Simon Chu
Private Credit
Jul 14, 2026

The Rise of Private Credit Is Reshaping Global Financial Markets

Private credit has evolved from a niche alternative strategy into a multi-trillion-dollar parallel lending market. Higher rates, stricter bank regulation, and demand for flexible financing have reshaped how capital flows through the global economy.

Pranav Bhongir
Biotech
Jul 13, 2026

Programmable Probiotics: Living Medicines Move Beyond the Gut

Probiotics are being re-engineered as programmable medicines capable of sensing disease, producing therapeutics, and altering metabolism from inside the body. But commercial enthusiasm remains well ahead of clinical evidence.

Kenzie Scott Wu
IPO
Jul 11, 2026

Who Actually Buys the Trillion-Dollar IPOs? Follow the Gulf

The 2026 IPO wave needs more capital than public markets typically provide. SpaceX, OpenAI, and Anthropic are seeking around $200 billion in new equity, and the only buyers large enough to anchor deals of this size are Gulf sovereign wealth funds financed by oil revenue.

Eric Tao
FinTech
Jul 10, 2026

Robinhood Chain and the Path to Mainstream Onchain Finance

Robinhood Chain brings 28 million funded customers to a permissionless, AI-native Layer 2 built for tokenized real-world assets and composable DeFi. The thesis is not about technical specs or speculative momentum — it is about distribution scale, regulatory positioning, and tangible utility.

Quorix
Biotech
Jul 6, 2026

GLP-1 in a Capsule? The Supplement Boom Chasing Ozempic

The most valuable opportunity in the GLP-1 supplement wave is not a pill that replaces Ozempic. It is the ecosystem forming around it — on-drug support products and post-drug maintenance brands built for a large, fast-growing patient population.

Diana Dai
Artificial Intelligence
Jul 2, 2026

Agentic AI May First Win by Fixing Enterprise Coordination

Most coverage frames agentic AI as a job-replacement story, but the first real wins will be in closing gaps between teams, systems, and decisions inside fragmented enterprises. The value is not in doing a person's whole job — it is in making workflows finally connect.

Alice Liu
FinTech
Jun 28, 2026

The New AI Bottleneck: Why CPUs Are Suddenly Back in Demand

The recent rise in CPU demand is not simply a broad semiconductor recovery; it reflects a more specific change in how AI is being deployed in production environments.

Jacky Chan
FinTechInterest Rate
Jun 22, 2026

Interest Rate Changes Push Fintech Companies to Chase Banking Licenses

Interest rates significantly affect the value of money within a fintech platform. This relationship is central to understanding why more fintech companies are pursuing banking licenses.

Simon Chu
Biotech
Jun 18, 2026

Human Milk Oligosaccharides: Precision Fermentation's Next Supplement Opportunity

Once confined to breast milk and infant formula, human milk oligosaccharides are moving into microbiome-focused supplements as precision fermentation unlocks scalable production. However, adult-health claims remain ahead of the evidence.

Kenzie Scott Wu
Physical Intelligence
Jun 16, 2026

The Next Hard Test for Robotics

The AI industry is shifting from digital tasks to physical action. Physical intelligence — AI that can perceive, reason, plan and act in the real world — is one of the most important and difficult next stages of AI, facing challenges in safety, hardware, data and real-world deployment.

Alice Liu
IPO
Jun 12, 2026

Will SpaceX Stock Crash After the IPO Like Other Mega-Tech Listings?

SpaceX stock is likely to experience notable short-term volatility following its IPO, consistent with patterns seen in large tech listings. However, a sustained crash is not the most probable outcome given Starlink's real revenue base and strong institutional demand.

Quorix
Artificial Intelligence
Jun 8, 2026

The Inference Economy: AI's Next Margin War

As generative AI moves from experimentation to mass deployment, the industry's next battleground is inference economics — who can deliver useful intelligence at the lowest cost. With $700B in infrastructure spending planned for 2026, the margin war is just beginning.

Alice Liu
Cross-Asset Risks
Jun 6, 2026

Bond Market Pressure & Equity Vulnerability

Rising long-term yields have quietly become the dominant headwind for global equities in early June 2026. Capital is shifting from risk assets into bonds and cash at the fastest pace seen this year, as sticky inflation and resilient jobs data push back Fed rate cut expectations.

Quorix
FinTech
Jun 4, 2026

Agentic Commerce Payment Infrastructure

Agentic commerce changes the way payments happen. As AI agents begin to handle shopping, negotiation, purchasing, and reconciliation on behalf of users, payment systems will need a new trust infrastructure that controls identity, permissions, and risk — far beyond basic stored-card access.

Simon Chu
Biotech
Jun 2, 2026

The Peptide Surge: Plant-Based Hype Meets Overlooked Risks

The global peptide supplements market is projected to reach USD 11.2 billion by 2035, driven by biohackers and longevity seekers. Plant-derived peptides are the fastest-growing segment — but most claims outpace the science, regulatory oversight is thin, and long-term risks remain largely unmapped.

Quorix
Artificial Intelligence
May 25, 2026

Can the Market Absorb the Mega-IPOs of SpaceX, OpenAI, and Anthropic?

SpaceX, OpenAI, and Anthropic are racing toward IPOs that could collectively raise over $200 billion and push combined market capitalizations toward $4 trillion — the most consequential public-market stress test the AI boom has ever faced.

Quorix
Commodities
May 8, 2026

Is Gold's Safety Status Overstated?

Gold has historically been regarded as a premier safe haven asset, yet in an era of elevated real yields, persistent geopolitical tensions, and shifting central bank behaviors, its role merits fresh scrutiny.

Quorix
Artificial Intelligence
May 2, 2026

OpenAI, the Most Expensive AI Gamble in History

OpenAI tripled revenue to $13.1 billion in 2025 while projecting losses of up to $25 billion in 2026, raising fundamental questions about whether frontier-scale AI investment can align with durable economics.

Quorix
Geopolitics
Apr 27, 2026

Iran's New Proposal to Reopen the Strait of Hormuz: Progress Amid Geopolitical Energy Shock

Over the weekend of April 25–26, Iran delivered a new phased proposal to the United States via Pakistani mediators, focusing on reopening the Strait of Hormuz and lifting the U.S. naval blockade. This marks the most concrete diplomatic move since the April 7 ceasefire, arriving as markets and central banks grapple with stagflationary fallout from the U.S.-Iran conflict.

Quorix
Biotech
Apr 4, 2026

Gene Therapy Ear Injection Restores Hearing

A landmark multicenter trial in China delivers compelling proof-of-concept for AAV-mediated OTOF gene replacement, with rapid functional hearing gains across toddlers to young adults and a clean safety profile — accelerating the race toward the first approved inner-ear gene therapies.

Quorix
FinTech
Apr 1, 2026

Quantum Computing Developments and Their Implications for Cryptocurrency Security

Quantum computing is maturing fast — while not an immediate threat, its implications for blockchain cryptography demand proactive post-quantum security measures from crypto projects today.

Quorix
Physical Intelligence
Mar 24, 2026

Physical Intelligence: AI's Decisive Leap into the World of Atoms

Physical Intelligence marks AI's decisive leap from the abstract 'world of bits' into the tangible 'world of atoms,' powered by 2026 breakthroughs from leaders such as Tesla and NVIDIA.

Quorix
Biotech
Mar 17, 2026

The Longevity Supplement Surge

Longevity science turns supplements into a surging $4.8B-to-$9B mainstream boom, as NMN, NAD+, resveratrol, and spermidine move from biohacker labs to supermarket shelves.

Quorix
FinTech
Mar 10, 2026

The Downfall of Initial Coin Offering (ICO)

The ICO model that raised billions in 2017 has devolved into a pattern of retail losses, with 85% of 2025 token launches trading below their TGE entry prices and median retail losses exceeding 70%.

Quorix
Artificial Intelligence
Mar 8, 2026

AI Agents and the Future of Financial Transactions

Autonomous AI agents are emerging as independent participants in global payment systems, capable of monitoring conditions and executing transactions without ongoing human oversight.

Quorix
Physical Intelligence
Mar 6, 2026

The Rise of Drone Technology

Drones are proving automation's true power: machines that perceive, decide, and act in the physical world at scale.

Quorix